BR9302433A - Composto,composicao farmaceutica,processos para tratar infeccoes virais e neoplasmas - Google Patents
Composto,composicao farmaceutica,processos para tratar infeccoes virais e neoplasmasInfo
- Publication number
- BR9302433A BR9302433A BR9302433A BR9302433A BR9302433A BR 9302433 A BR9302433 A BR 9302433A BR 9302433 A BR9302433 A BR 9302433A BR 9302433 A BR9302433 A BR 9302433A BR 9302433 A BR9302433 A BR 9302433A
- Authority
- BR
- Brazil
- Prior art keywords
- neoplasms
- processes
- compound
- pharmaceutical composition
- viral infections
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90230492A | 1992-06-22 | 1992-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9302433A true BR9302433A (pt) | 1994-01-11 |
Family
ID=25415652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9302433A BR9302433A (pt) | 1992-06-22 | 1993-06-21 | Composto,composicao farmaceutica,processos para tratar infeccoes virais e neoplasmas |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0576227A3 (pt) |
JP (1) | JPH0656877A (pt) |
KR (1) | KR940005656A (pt) |
CN (1) | CN1084178A (pt) |
AU (1) | AU4134793A (pt) |
BR (1) | BR9302433A (pt) |
CA (1) | CA2098876A1 (pt) |
CZ (1) | CZ123293A3 (pt) |
FI (1) | FI932868A (pt) |
HU (1) | HUT64553A (pt) |
IL (1) | IL106073A0 (pt) |
MX (1) | MX9303709A (pt) |
NO (1) | NO932287L (pt) |
PL (1) | PL299412A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5637688A (en) * | 1994-12-13 | 1997-06-10 | Eli Lilly And Company | Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride |
US6214801B1 (en) | 1996-01-23 | 2001-04-10 | The Regents Of The University Of Michigan | Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents |
KR100412480B1 (ko) * | 1996-10-16 | 2003-12-31 | 아이씨엔 파마슈티컬스, 인코포레이티드 | 푸린 l-누클레오시드, 이의 유사체 및 이들의 용도 |
TW466112B (en) * | 1998-04-14 | 2001-12-01 | Lilly Co Eli | Novel use of 2'-deoxy-2',2'-difluorocytidine for immunosuppressive therapy and pharmaceutical composition comprising the same |
WO2003062256A1 (en) * | 2002-01-17 | 2003-07-31 | Ribapharm Inc. | 2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents |
CN1293884C (zh) * | 2002-10-29 | 2007-01-10 | 南京长澳医药科技有限公司 | 6-甲氧基双脱氧鸟苷在制备抗乙肝药物中的应用 |
JP5002851B2 (ja) * | 2005-01-20 | 2012-08-15 | 独立行政法人理化学研究所 | イミダゾピリジン誘導体 |
CN100391966C (zh) * | 2005-06-17 | 2008-06-04 | 华东师范大学 | 一种2’-脱氧-2’,2’-二氟-胞苷合成的方法 |
AT502635A1 (de) * | 2005-11-09 | 2007-05-15 | Saischek Und Partner Meg | Neue 1,3-dithioverbindungen, verfahren zu deren herstellung und ihre verwendung |
MX2009005879A (es) * | 2006-12-13 | 2009-09-09 | Givaudan Nederland Services B | Derivado modulador del sabor de un acido carboxilico y una purina, pirimidina, nucleosido o nucleotido. |
CN101557725B (zh) * | 2006-12-13 | 2013-09-18 | 奇华顿荷兰服务有限责任公司 | 羧酸和嘌呤、嘧啶、核苷或核苷酸的风味调节衍生物 |
CN106317147B (zh) * | 2015-07-06 | 2018-11-27 | 扬州硒瑞恩生物医药科技有限公司 | 核苷类化合物及其制备方法 |
JP6983814B2 (ja) * | 2016-12-14 | 2021-12-17 | ヤマサ醤油株式会社 | 抗ウイルス活性を示すヌクレオシド誘導体 |
JP7084591B2 (ja) * | 2017-03-29 | 2022-06-15 | ヤマサ醤油株式会社 | ヌクレオシド誘導体又はその塩、及びそれを含む医薬組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE92499T1 (de) * | 1984-12-04 | 1993-08-15 | Lilly Co Eli | Tumorbehandlung bei saeugetieren. |
CA1295998C (en) * | 1985-07-29 | 1992-02-18 | Sai P. Sunkara | Nucleosides and their use as antineoplastic agents |
US4914028A (en) * | 1988-02-10 | 1990-04-03 | Eli Lilly And Company | Method of preparing beta-2',2'-difluoronucleosides |
ES2075040T3 (es) * | 1988-02-16 | 1995-10-01 | Lilly Co Eli | 2',3'-dideoxi-2',2'-difluoronucleosidos. |
-
1993
- 1993-06-18 AU AU41347/93A patent/AU4134793A/en not_active Abandoned
- 1993-06-21 HU HU9301821A patent/HUT64553A/hu unknown
- 1993-06-21 CN CN93107740A patent/CN1084178A/zh active Pending
- 1993-06-21 NO NO932287A patent/NO932287L/no unknown
- 1993-06-21 PL PL29941293A patent/PL299412A1/xx unknown
- 1993-06-21 JP JP5149191A patent/JPH0656877A/ja not_active Withdrawn
- 1993-06-21 IL IL106073A patent/IL106073A0/xx unknown
- 1993-06-21 CZ CZ931232A patent/CZ123293A3/cs unknown
- 1993-06-21 MX MX9303709A patent/MX9303709A/es unknown
- 1993-06-21 BR BR9302433A patent/BR9302433A/pt not_active Application Discontinuation
- 1993-06-21 CA CA002098876A patent/CA2098876A1/en not_active Abandoned
- 1993-06-21 KR KR1019930011308A patent/KR940005656A/ko not_active Application Discontinuation
- 1993-06-21 EP EP19930304815 patent/EP0576227A3/en not_active Withdrawn
- 1993-06-21 FI FI932868A patent/FI932868A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI932868A (fi) | 1993-12-23 |
HUT64553A (en) | 1994-01-28 |
EP0576227A2 (en) | 1993-12-29 |
PL299412A1 (en) | 1993-12-27 |
IL106073A0 (en) | 1993-10-20 |
AU4134793A (en) | 1993-12-23 |
CN1084178A (zh) | 1994-03-23 |
CZ123293A3 (en) | 1994-03-16 |
NO932287D0 (no) | 1993-06-21 |
NO932287L (no) | 1993-12-23 |
CA2098876A1 (en) | 1993-12-23 |
MX9303709A (es) | 1994-05-31 |
FI932868A0 (fi) | 1993-06-21 |
KR940005656A (ko) | 1994-03-22 |
EP0576227A3 (en) | 1994-02-09 |
HU9301821D0 (en) | 1993-09-28 |
JPH0656877A (ja) | 1994-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
BR9203032A (pt) | Material esponjoso de liberacao lenta,processo para preparar o mesmo,preparacoes farmaceuticas e processo terapeutico | |
DK0973735T3 (da) | Polyaromatiske antivirale præparater | |
PT98944A (pt) | Processo de preparacao de anticorpos alterados e de composicoes farmaceuticas para a prevencao e tratamento de infeccoes | |
BR9205142A (pt) | Composicao inseticida,e,processo para produzi-la | |
NO179941C (no) | Farmasöytisk forbindelse | |
BR9302433A (pt) | Composto,composicao farmaceutica,processos para tratar infeccoes virais e neoplasmas | |
BR8904519A (pt) | Composicao fungicida,processos para preparar compostos fungicidas e para preparar compostos de benzoilacetonitrila | |
BR9100046A (pt) | Derivados de azaoxindole,composicao farmaceutica e processo para o tratamento de mamiferos | |
BR9301342A (pt) | Composto,formulacao e composicao farmaceutica,processo para preparar um composto | |
BR9302389A (pt) | Composto,formulacao farmaceutica e processo para preparar o composto | |
NO934145L (no) | Farmasöytiske forbindelser | |
FI931251A (fi) | Farmaceutiska foereningar | |
LV10191A (lv) | Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai | |
FI935654A (fi) | Kondensoituneet heterosykliset yhdisteet, niiden valmistus ja käyttö | |
IL110511A0 (en) | Topical pharmaceutical formulation for treating viral infections | |
FI965114A0 (fi) | Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä | |
BR8901359A (pt) | Processo para a preparacao de compostos,composicoes,aplicacao e processo para combater insetos | |
FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
ITRM920305A1 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. | |
BR9303367A (pt) | Pacote,borracha composta e processo para preparar borracha composta | |
EE9400182A (et) | Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu | |
FI934317A0 (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
BR9200918A (pt) | Composto aroamtico,processo para produzir o mesmo,composicao e processo para controlar pragas de insetos uso do referido composto | |
BR9201408A (pt) | Composto de dna,sequencia de dna,composto polipeptidico e composicao farmaceutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
HKFN | Application deemed withdrawn (deleted) | ||
FA7 | Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health |